CREDITRISKMONITOR COM INC, 10-Q filed on 13 May 20
v3.20.1
Document and Entity Information - shares
3 Months Ended
Mar. 31, 2020
May 06, 2020
Cover [Abstract]    
Entity Registrant Name CREDITRISKMONITOR COM INC  
Entity Central Index Key 0000315958  
Current Fiscal Year End Date --12-31  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Shell Company false  
Entity Filer Category Non-accelerated Filer  
Entity Small Business true  
Entity Emerging Growth Company false  
Entity Common Stock, Shares Outstanding   10,722,401
Document Type 10-Q  
Amendment Flag false  
Document Period End Date Mar. 31, 2020  
Document Fiscal Year Focus 2020  
Document Fiscal Period Focus Q1  
Entity Address, State or Province NY  
v3.20.1
CONDENSED BALANCE SHEETS (Unaudited) - USD ($)
Mar. 31, 2020
Dec. 31, 2019
Current assets:    
Cash and cash equivalents $ 8,298,301 $ 8,275,836
Accounts receivable, net of allowance 2,195,081 2,287,921
Other current assets 624,148 549,821
Total current assets 11,117,530 11,113,578
Property and equipment, net 461,907 477,973
Operating lease right-to-use asset 2,336,354 2,380,974
Goodwill 1,954,460 1,954,460
Other assets 46,654 35,723
Total assets 15,916,905 15,962,708
Current liabilities:    
Unexpired subscription revenue 9,186,434 8,651,843
Accounts payable 186,747 137,500
Current portion of operating lease liability 150,805 147,229
Accrued expenses 929,891 1,344,550
Total current liabilities 10,453,877 10,281,122
Deferred taxes on income, net 455,850 521,765
Unexpired subscription revenue, less current portion 235,626 166,169
Operating lease liability, less current portion 2,260,453 2,299,433
Total liabilities 13,405,806 13,268,489
Stockholders' equity:    
Preferred stock, $.01 par value; authorized 5,000,000 shares; none issued 0 0
Common stock, $.01 par value; authorized 32,500,000 shares; issued and outstanding 10,722,401 shares 107,224 107,224
Additional paid-in capital 29,720,901 29,705,673
Accumulated deficit (27,317,026) (27,118,678)
Total stockholders' equity 2,511,099 2,694,219
Total liabilities and stockholders' equity $ 15,916,905 $ 15,962,708
v3.20.1
CONDENSED BALANCE SHEETS (Unaudited) (Parenthetical) - $ / shares
Mar. 31, 2020
Dec. 31, 2019
Stockholders' equity:    
Preferred stock, par value (in dollars per share) $ 0.01 $ 0.01
Preferred stock, authorized (in shares) 5,000,000 5,000,000
Preferred stock, issued (in shares) 0 0
Common stock, par value (in dollars per share) $ 0.01 $ 0.01
Common stock, authorized (in shares) 32,500,000 32,500,000
Common stock, issued (in shares) 10,722,401 10,722,401
Common stock, outstanding (in shares) 10,722,401 10,722,401
v3.20.1
CONDENSED STATEMENTS OF OPERATIONS (Unaudited) - USD ($)
3 Months Ended
Mar. 31, 2020
Mar. 31, 2019
CONDENSED STATEMENTS OF OPERATIONS (Unaudited) [Abstract]    
Operating revenues $ 3,708,751 $ 3,495,809
Operating expenses:    
Data and product costs 1,526,328 1,468,993
Selling, general and administrative expenses 2,415,258 2,167,411
Depreciation and amortization 54,112 50,989
Total operating expenses 3,995,698 3,687,393
Loss from operations (286,947) (191,584)
Other income, net 22,684 40,890
Loss before income taxes (264,263) (150,694)
Benefit from income taxes 65,915 14,226
Net loss $ (198,348) $ (136,468)
Net loss per share - Basic and diluted (in dollars per share) $ (0.02) $ (0.01)
Weighted average number of common shares outstanding - Basic and diluted (in shares) 10,722,401 10,722,401
v3.20.1
CONDENSED STATEMENTS OF STOCKHOLDERS' EQUITY (Unaudited) - USD ($)
Common Stock [Member]
Additional Paid-in Capital [Member]
Accumulated Deficit [Member]
Total
Balance at Dec. 31, 2018 $ 107,224 $ 29,650,760 $ (26,800,152) $ 2,957,832
Balance (in shares) at Dec. 31, 2018 10,722,401      
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net loss $ 0 0 (136,468) (136,468)
Stock-based compensation 0 14,264 0 14,264
Balance at Mar. 31, 2019 $ 107,224 29,665,024 (26,936,620) 2,835,628
Balance (in shares) at Mar. 31, 2019 10,722,401      
Balance at Dec. 31, 2019 $ 107,224 29,705,673 (27,118,678) $ 2,694,219
Balance (in shares) at Dec. 31, 2019 10,722,401     10,722,401
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net loss $ 0 0 (198,348) $ (198,348)
Stock-based compensation 0 15,228 0 15,228
Balance at Mar. 31, 2020 $ 107,224 $ 29,720,901 $ (27,317,026) $ 2,511,099
Balance (in shares) at Mar. 31, 2020 10,722,401     10,722,401
v3.20.1
CONDENSED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)
3 Months Ended
Mar. 31, 2020
Mar. 31, 2019
Cash flows from operating activities:    
Net loss $ (198,348) $ (136,468)
Adjustments to reconcile net loss to net cash provided by operating activities:    
Deferred income taxes (65,915) (14,226)
Depreciation and amortization 54,112 50,989
Operating lease right-to-use asset, net 9,216 11,052
Stock-based compensation 15,228 14,264
Changes in operating assets and liabilities:    
Accounts receivable 92,840 500,477
Other current assets (74,327) (93,454)
Other assets (10,931) (8,900)
Unexpired subscription revenue 604,048 381,604
Accounts payable 49,247 131,667
Accrued expenses (414,659) (474,100)
Net cash provided by operating activities 60,511 362,905
Cash flows from investing activities:    
Purchase of property and equipment (38,046) (39,851)
Net cash used in investing activities (38,046) (39,851)
Net increase in cash and cash equivalents 22,465 323,054
Cash and cash equivalents at beginning of period 8,275,836 8,066,899
Cash and cash equivalents at end of period $ 8,298,301 $ 8,389,953
v3.20.1
Basis of Presentation
3 Months Ended
Mar. 31, 2020
Basis of Presentation [Abstract]  
Basis of Presentation
(1) Basis of Presentation

The accompanying unaudited condensed financial statements of CreditRiskMonitor.com, Inc. (the “Company”) have been prepared in accordance with accounting principles generally accepted in the United States for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Certain information and footnote disclosure required by generally accepted accounting principles (“GAAP”) in the United States for complete financial statements have been condensed or omitted pursuant to the rules and regulations of the Securities and Exchange Commission (the “SEC”). In the opinion of management, the accompanying unaudited condensed financial statements reflect all material adjustments, including normal recurring accruals, necessary to present fairly the Company’s financial position, results of operations and cash flows for the periods presented, and have been prepared in a manner consistent with the audited financial statements for the fiscal year ended December 31, 2019.

The results of operations for the three months ended March 31, 2020 and 2019 are not necessarily indicative of the results for an entire fiscal year.

The December 31, 2019 balance sheet has been derived from the audited financial statements at that date, but does not include all disclosures required by GAAP. These financial statements should be read in conjunction with the audited financial statements and the footnotes for the fiscal year ended December 31, 2019 included in the Company’s Annual Report on Form 10-K.
v3.20.1
Recently Issued Accounting Standards
3 Months Ended
Mar. 31, 2020
Recently Issued Accounting Standards [Abstract]  
Recently Issued Accounting Standards
(2) Recently Issued Accounting Standards

The Financial Accounting Standards Board and the SEC have issued certain accounting pronouncements that will become effective in subsequent periods; however, management does not believe that any of those pronouncements would have significantly affected the Company’s financial accounting measurements or disclosures had they been in effect during the interim periods for which financial statements are included in this quarterly report. Management also believes those pronouncements will not have a significant effect on the Company’s future financial position or results of operations.
v3.20.1
Revenue Recognition
3 Months Ended
Mar. 31, 2020
Revenue Recognition [Abstract]  
Revenue Recognition
(3) Revenue Recognition

The Company applies ASC 606, Revenue from Contract with Customers (“ASC 606”) to recognize revenue. ASC 606 requires an entity to apply the following five-step approach: (1) identify the contract(s) with a customer; (2) identify each performance obligation in the contract; (3) determine the transaction price; (4) allocate the transaction price to each performance obligation; and (5) recognize revenue when or as each performance obligation is satisfied. The Company’s primary source of revenue is subscription income which is recognized ratably over the subscription term.
v3.20.1
Stock-Based Compensation
3 Months Ended
Mar. 31, 2020
Stock-Based Compensation [Abstract]  
Stock-Based Compensation
(4) Stock-Based Compensation

The Company applies ASC 718, Compensation-Stock Compensation (“ASC 718”) to account for stock-based compensation.

The following table summarizes the stock-based compensation expense for stock options that was recorded in the Company’s results of operations in accordance with ASC 718 for the three months ended March 31:

  
2020
  
2019
 
       
Data and product costs
 
$
5,583
  
$
6,440
 
Selling, general and administrative expenses
  
9,645
   
7,824
 
         
  
$
15,228
  
$
14,264
 
v3.20.1
Fair Value Measurements
3 Months Ended
Mar. 31, 2020
Fair Value Measurements [Abstract]  
Fair Value Measurements
(5) Fair Value Measurements

The Company records its financial instruments at fair value in accordance with accounting guidance. The determination of fair value assumes that the transaction to sell an asset or transfer a liability occurs in the principal market for the asset or liability or, in the absence of a principal market, the most advantageous market for the asset or liability. The fair value hierarchy is broken down into three levels based on the source of inputs as follows: (a) Level 1 – valuations based on unadjusted quoted prices in active markets that are accessible at the measurement date for identical, unrestricted assets or liabilities; (b) Level 2 – valuations based on quoted prices in markets that are not active, or financial instruments for which all significant inputs are observable, either directly or indirectly; and (c) Level 3 – valuations based on prices or valuation techniques that require inputs that are both significant to the fair value measurement and unobservable, thus, reflecting assumptions about the market participants.

The Company’s cash and cash equivalents are stated at fair value. The carrying value of accounts receivable, other current assets, accounts payable and other current liabilities approximates fair market value because of the short maturity of these financial instruments.

The Company’s cash equivalents are generally classified within Level 1 of the fair value hierarchy because they are valued using quoted market prices.

The table below sets forth the Company’s cash and cash equivalents as of March 31, 2020 and December 31, 2019, respectively, which are measured at fair value on a recurring basis by level within the fair value hierarchy.

  
March 31, 2020
 
  
Level 1
  
Level 2
  
Level 3
  
Total
 
             
Cash and cash equivalents
 
$
8,298,301
  
$
-
  
$
-
  
$
8,298,301
 

  
December 31, 2019
 
  
Level 1
  
Level 2
  
Level 3
  
Total
 
             
Cash and cash equivalents
 
$
8,275,836
  
$
-
  
$
-
  
$
8,275,836
 

The Company did not hold financial assets and liabilities which were recorded at fair value in the Level 2 or 3 categories as of either March 31, 2020 or December 31, 2019.
v3.20.1
Net Loss per Share
3 Months Ended
Mar. 31, 2020
Net Loss per Share [Abstract]  
Net Loss per Share
(6) Net Loss per Share

During the three months ended March 31, 2020 and 2019 the Company recorded a net loss. Basic net loss per share is computed by dividing the net loss by the weighted average number of common shares outstanding during the period. Because the Company has reported a net loss for all periods presented, diluted net loss per share is the same as basic net loss per share, as the effect of utilizing the fully diluted share count would have reduced the net loss per share. Therefore, all outstanding stock options were excluded from the computation of diluted net loss per share because their effect was anti-dilutive for each of the periods presented.
v3.20.1
Related Party Transaction
3 Months Ended
Mar. 31, 2020
Related Party Transaction [Abstract]  
Related Party Transaction
(7) Related Party Transaction

On October 24, 2019, the Company’s Board of Directors appointed Michael Flum to serve as Senior Vice President and Chief Operating Officer effective immediately. Mr. Flum had served as Vice President of Operations & Alternative Data since June 4, 2018. Mr. Flum is the son of Jerome Flum, the Company’s Chief Executive Officer and Chairman of the Board of Directors, and the brother of Joshua Flum, a director of the Company.
v3.20.1
COVID-19
3 Months Ended
Mar. 31, 2020
COVID-19 [Abstract]  
COVID-19
(8) COVID-19

On March 11, 2020, the World Health Organization declared the outbreak of Coronavirus Disease 2019 (“COVID-19” or “virus”) as a global pandemic. The full impact of COVID-19 is unknown and rapidly evolving. The outbreak and any preventative or protective actions that the Company or its customers may take in respect of this virus may result in a period of disruption, including the Company’s financial reporting capabilities, its operations generally and could potentially impact the Company’s customers, data providers and other third parties. Any resulting financial impact cannot be reasonably estimated at this time, but may materially affect the business and the Company’s financial condition and results of operations. The extent to which the COVID-19 impacts the Company’s results will depend on future developments, which are highly uncertain and cannot be predicted, including new information which may emerge concerning the severity of COVID-19 and the actions to contain the virus or treat its impact, among others. The Company has been operating remotely without any disruption of operations. To date, the Company’s data providers have provided an uninterrupted stream of information thus enabling the Company to deliver its product. The Company is currently evaluating the impact, if any, on its financial statements and has not yet quantified what material impacts to the financial statements may result from the actions taken by the Company and its customers in respect of this virus.

In response to COVID-19, President Donald Trump signed into law the Coronavirus Aid, Relief, and Economic Security Act (the “CARES Act”) on March 27, 2020. The CARES Act provides numerous tax provisions and other stimulus measures, including temporary changes regarding the prior and future utilization of net operating losses, temporary changes to the prior and future limitations on interest deductions, temporary suspension of certain payment requirements for the employer portion of Social Security taxes, technical corrections from prior tax legislation for tax depreciation of certain qualified improvement property, and the creation of certain refundable employee retention credits. Additionally, the CARES Act contains relief for small businesses through several new temporary programs, one of which is the Paycheck Protection Program (“PPP”). The PPP is a loan designed to provide a direct incentive for small businesses to keep their workers on the payroll. The Small Business Administration (“SBA”) will forgive loans if all employees are kept on the payroll for eight weeks and the money is used for payroll, rent or utilities. The Company applied for a loan under this program and has received $1.56 million. In accordance with the requirements of the CARES Act, the Company intends to use the proceeds from the PPP Loan primarily for payroll costs. The PPP loan is scheduled to mature on April 15, 2022, has a 1.00% interest rate, may be prepaid at any time without penalty and is subject to the terms and conditions applicable to all loans made pursuant to the PPP as administered by the SBA under the CARES Act. The loan and accrued interest is forgivable after eight weeks so long as the Company uses the loan proceeds for eligible purposes, including payroll, benefits, rent and utilities, and maintains its payroll levels.  The amount of loan forgiveness will be reduced if the Company terminates employees or reduces salaries during the eight-week period.
v3.20.1
Stock-Based Compensation (Tables)
3 Months Ended
Mar. 31, 2020
Stock-Based Compensation [Abstract]  
Stock-based Compensation Expense for Stock Options
The following table summarizes the stock-based compensation expense for stock options that was recorded in the Company’s results of operations in accordance with ASC 718 for the three months ended March 31:

  
2020
  
2019
 
       
Data and product costs
 
$
5,583
  
$
6,440
 
Selling, general and administrative expenses
  
9,645
   
7,824
 
         
  
$
15,228
  
$
14,264
 
v3.20.1
Fair Value Measurements (Tables)
3 Months Ended
Mar. 31, 2020
Fair Value Measurements [Abstract]  
Cash and Cash Equivalents Measured at Fair Value on Recurring Basis
The table below sets forth the Company’s cash and cash equivalents as of March 31, 2020 and December 31, 2019, respectively, which are measured at fair value on a recurring basis by level within the fair value hierarchy.

  
March 31, 2020
 
  
Level 1
  
Level 2
  
Level 3
  
Total
 
             
Cash and cash equivalents
 
$
8,298,301
  
$
-
  
$
-
  
$
8,298,301
 

  
December 31, 2019
 
  
Level 1
  
Level 2
  
Level 3
  
Total
 
             
Cash and cash equivalents
 
$
8,275,836
  
$
-
  
$
-
  
$
8,275,836
 
v3.20.1
Stock-Based Compensation (Details) - USD ($)
3 Months Ended
Mar. 31, 2020
Mar. 31, 2019
Stock-based compensation expense for stock options [Abstract]    
Stock-based compensation expense $ 15,228 $ 14,264
Data and Product Costs [Member]    
Stock-based compensation expense for stock options [Abstract]    
Stock-based compensation expense 5,583 6,440
Selling, General and Administrative Expenses [Member]    
Stock-based compensation expense for stock options [Abstract]    
Stock-based compensation expense $ 9,645 $ 7,824
v3.20.1
Fair Value Measurements (Details) - Recurring [Member] - USD ($)
Mar. 31, 2020
Dec. 31, 2019
Cash and cash equivalents measured at fair value on recurring basis [Abstract]    
Cash and cash equivalents $ 8,298,301 $ 8,275,836
Level 1 [Member]    
Cash and cash equivalents measured at fair value on recurring basis [Abstract]    
Cash and cash equivalents 8,298,301 8,275,836
Level 2 [Member]    
Cash and cash equivalents measured at fair value on recurring basis [Abstract]    
Cash and cash equivalents 0 0
Level 3 [Member]    
Cash and cash equivalents measured at fair value on recurring basis [Abstract]    
Cash and cash equivalents $ 0 $ 0
v3.20.1
COVID-19 (Details) - COVID-19 [Member] - PPP Loan [Member] - USD ($)
$ in Thousands
3 Months Ended
Mar. 27, 2020
Mar. 31, 2020
Loans Payable [Abstract]    
Proceeds from loans $ 1,560  
Maturity date   Apr. 15, 2022
Interest rate 1.00%